Sun Pharmaceutical Unit Gets FDA Warning - Wall Street Journal
Tue, 31 Aug 2010 15:59:36 GMT+00:00
Unit Gets FDA Warning Wall Street Journal bangalore sun Pharmaceutical Industries Ltd. said Tuesday that its wholly owned US unit, Sun Pharmaceutical Industries Inc., ... us fda warns India's Sun Pharma on plant problems Reuters Sun Pharma receives US FDA nod for hyperactivity drug Economic Times FDA cites Sun Pharma for GMP violations FiercePharma International Business Times - Business Standard - Hindu Business Line
Tue, 31 Aug 2010 15:59:36 GMT+00:00
Unit Gets FDA Warning Wall Street Journal bangalore sun Pharmaceutical Industries Ltd. said Tuesday that its wholly owned US unit, Sun Pharmaceutical Industries Inc., ... us fda warns India's Sun Pharma on plant problems Reuters Sun Pharma receives US FDA nod for hyperactivity drug Economic Times FDA cites Sun Pharma for GMP violations FiercePharma International Business Times - Business Standard - Hindu Business Line
Radient Pharmaceuticals Resumes Collaboration to Advance Its Onko-Sure(R) In ... - MarketWatch (press release)
Tue, 31 Aug 2010 12:52:07 GMT+00:00
Resumes Collaboration to Advance Its Onko-Sure(R) In ... MarketWatch (press release) This marks a critical and potentially market changing milestone for Radient Pharmaceuticals and for our Onko-Sure(R) IVD cancer test," commented Douglas ...
Tue, 31 Aug 2010 12:52:07 GMT+00:00
Resumes Collaboration to Advance Its Onko-Sure(R) In ... MarketWatch (press release) This marks a critical and potentially market changing milestone for Radient Pharmaceuticals and for our Onko-Sure(R) IVD cancer test," commented Douglas ...
Chindex sells $14 million in stock to Fosun Pharma - The Associated Press
Fri, 27 Aug 2010 15:12:48 GMT+00:00
The Associated Press The medical device maker said in June that it was teaming up with Shanghai Fosun Pharmaceutical Co. Ltd. to manufacture and distribute medical devices in ... Fosun Pharma Acquires $14 Million of Chindex Stock MarketWatch (press release)
Fri, 27 Aug 2010 15:12:48 GMT+00:00
The Associated Press The medical device maker said in June that it was teaming up with Shanghai Fosun Pharmaceutical Co. Ltd. to manufacture and distribute medical devices in ... Fosun Pharma Acquires $14 Million of Chindex Stock MarketWatch (press release)
Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for ... - PR Newswire (press release)
Wed, 01 Sep 2010 10:46:10 GMT+00:00
Receives European Marketing Authorisation for PecFent(R) for ... PR Newswire (press release) [ii] PecFent contains fentanyl, a highly potent opioid analgesic and uses an Archimedes Pharma nasal drug delivery system (PecSys(TM)) to deliver fentanyl ... Archimedes Pharma PecFent nasal spray gets EC marketing authorisation Pharmaceutical Business Review Archimedes snags EMA approval for new pain therapy FierceBiotech Archimedes Pharma Gets EU Marketing Authorization For Nasal Spray PecFent ... Stock Markets Review Genetic Engineering News - Science 2.0 (press release)
Wed, 01 Sep 2010 10:46:10 GMT+00:00
Receives European Marketing Authorisation for PecFent(R) for ... PR Newswire (press release) [ii] PecFent contains fentanyl, a highly potent opioid analgesic and uses an Archimedes Pharma nasal drug delivery system (PecSys(TM)) to deliver fentanyl ... Archimedes Pharma PecFent nasal spray gets EC marketing authorisation Pharmaceutical Business Review Archimedes snags EMA approval for new pain therapy FierceBiotech Archimedes Pharma Gets EU Marketing Authorization For Nasal Spray PecFent ... Stock Markets Review Genetic Engineering News - Science 2.0 (press release)
Endo Pharma plans $144 M Penwest acquisition - BusinessWeek
Mon, 09 Aug 2010 22:29:57 GMT+00:00
plans $144 M Penwest acquisition BusinessWeek Endo Pharmaceuticals plans to buy Penwest Pharmaceuticals Co., its partner in the development of pain drug Opana ER, in a deal valued at about $144 million. ... Endo acquires PenWest Pharma . ILNS awarded patent. Curis drug needs more analysis BioMedReports (subscription) (blog)
Mon, 09 Aug 2010 22:29:57 GMT+00:00
plans $144 M Penwest acquisition BusinessWeek Endo Pharmaceuticals plans to buy Penwest Pharmaceuticals Co., its partner in the development of pain drug Opana ER, in a deal valued at about $144 million. ... Endo acquires PenWest Pharma . ILNS awarded patent. Curis drug needs more analysis BioMedReports (subscription) (blog)
Pharma layoffs plummet to 255 in August - FiercePharma
Wed, 01 Sep 2010 14:59:08 GMT+00:00
layoffs plummet to 255 in August FiercePharma After seeing pharma job cut numbers dwell in the thousands for several month, consulting firm Challenger, Gray and Christmas report that pharma layoffs ...
Wed, 01 Sep 2010 14:59:08 GMT+00:00
layoffs plummet to 255 in August FiercePharma After seeing pharma job cut numbers dwell in the thousands for several month, consulting firm Challenger, Gray and Christmas report that pharma layoffs ...
Quark Pharma inks drug deal with Novartis, eyes IPO - Reuters
Wed, 18 Aug 2010 20:31:52 GMT+00:00
inks drug deal with Novartis, eyes IPO Reuters bangalore, Aug 18 (Reuters) - Privately held Quark Pharmaceuticals Inc licensed its experimental kidney drug to Swiss giant Novartis ...
Wed, 18 Aug 2010 20:31:52 GMT+00:00
inks drug deal with Novartis, eyes IPO Reuters bangalore, Aug 18 (Reuters) - Privately held Quark Pharmaceuticals Inc licensed its experimental kidney drug to Swiss giant Novartis ...
Genzyme Spurns Buyout Offer From French Pharma - WBUR
Tue, 31 Aug 2010 13:12:56 GMT+00:00
wbur boston the biggest bio-tech company in Massachusetts has spurned a proposal from one of the world's biggest pharmaceutical firms. ... Sanofi Takes Bid For Genzyme Public Benzinga A 'Hostile' Reaction? Genzyme Rebuffs Sanofi Offer, Officially BioWorld Online Genzyme investors hold out for higher Sanofi bid FiercePharma TopNews United States - Sydney Morning Herald - Wall Street Journal
Tue, 31 Aug 2010 13:12:56 GMT+00:00
wbur boston the biggest bio-tech company in Massachusetts has spurned a proposal from one of the world's biggest pharmaceutical firms. ... Sanofi Takes Bid For Genzyme Public Benzinga A 'Hostile' Reaction? Genzyme Rebuffs Sanofi Offer, Officially BioWorld Online Genzyme investors hold out for higher Sanofi bid FiercePharma TopNews United States - Sydney Morning Herald - Wall Street Journal
Simcere Pharma 2Q Profit Climbs 3.6% As Revenue, Costs Jump - Wall Street Journal
Thu, 12 Aug 2010 10:52:23 GMT+00:00
2Q Profit Climbs 3.6% As Revenue, Costs Jump Wall Street Journal Simcere Pharmaceutical Group's (SCR) second-quarter earnings rose 3.6%, topping analysts' estimates, as the Chinese-focused pharmaceutical company' strong ... Simcere Pharma gets SFDA approval for Palonosetron manufacturing Pharmaceutical Business Review
Thu, 12 Aug 2010 10:52:23 GMT+00:00
2Q Profit Climbs 3.6% As Revenue, Costs Jump Wall Street Journal Simcere Pharmaceutical Group's (SCR) second-quarter earnings rose 3.6%, topping analysts' estimates, as the Chinese-focused pharmaceutical company' strong ... Simcere Pharma gets SFDA approval for Palonosetron manufacturing Pharmaceutical Business Review
SCOLR Pharma, Emerson sign nutritional, OTC products sales agreement - Pharmaceutical Business Review
Tue, 31 Aug 2010 07:36:01 GMT+00:00
, Emerson sign nutritional, OTC products sales agreement Pharmaceutical Business Review scolr pharma and the Emerson Group have entered into an agreement under which Emerson will provide sales support to SCOLR Pharma's new line of ... scolr pharma , Inc. Signs Agreement with The Emerson Group to Provide Sales ... PR Newswire (press release)
Tue, 31 Aug 2010 07:36:01 GMT+00:00
, Emerson sign nutritional, OTC products sales agreement Pharmaceutical Business Review scolr pharma and the Emerson Group have entered into an agreement under which Emerson will provide sales support to SCOLR Pharma's new line of ... scolr pharma , Inc. Signs Agreement with The Emerson Group to Provide Sales ... PR Newswire (press release)
Laxai Pharma, Ltd. Publishes Second Quarter Results and Adds New Business With ... - MarketWatch (press release)
Thu, 26 Aug 2010 20:37:04 GMT+00:00
, Ltd. Publishes Second Quarter Results and Adds New Business With ... MarketWatch (press release) Laxai Pharma Ltd. is a Contract Research Organization providing integrated services across the drug discovery and development spectrum. ...
Thu, 26 Aug 2010 20:37:04 GMT+00:00
, Ltd. Publishes Second Quarter Results and Adds New Business With ... MarketWatch (press release) Laxai Pharma Ltd. is a Contract Research Organization providing integrated services across the drug discovery and development spectrum. ...
Guess, 3Par, Momenta Pharma, TiVo big movers - The Associated Press
Thu, 26 Aug 2010 21:43:06 GMT+00:00
, TiVo big movers The Associated Press nasdaq momenta Pharmaceuticals Inc., up 17 cents at $15.85 A judge denied Sanofi-Aventis' request to suspend Momenta's generic version of Sanofi-Aventis' ...
Thu, 26 Aug 2010 21:43:06 GMT+00:00
, TiVo big movers The Associated Press nasdaq momenta Pharmaceuticals Inc., up 17 cents at $15.85 A judge denied Sanofi-Aventis' request to suspend Momenta's generic version of Sanofi-Aventis' ...
Cipla looks to acquire 25% stake in South African co - Economic Times
Fri, 03 Sep 2010 09:54:35 GMT+00:00
Economic Times The Mumbai-based pharma major, which is one of the largest pharmaceutical companies in the country, said the SA company's board has already approved the ... Cipla To Acquire 25% In Cipla Medpro's Manufacturing Unit DealCurry (blog)
Fri, 03 Sep 2010 09:54:35 GMT+00:00
Economic Times The Mumbai-based pharma major, which is one of the largest pharmaceutical companies in the country, said the SA company's board has already approved the ... Cipla To Acquire 25% In Cipla Medpro's Manufacturing Unit DealCurry (blog)
BioAlliance Pharma Announces the Launch of Oravig(R) on the US Market by Its ... - MarketWatch (press release)
Tue, 24 Aug 2010 16:36:56 GMT+00:00
Announces the Launch of Oravig(R) on the US Market by Its ... MarketWatch (press release) With a US FDA approval in April 2010, BioAlliance Pharma is the first small medium-sized innovative French company to have access to the American market, ...
Tue, 24 Aug 2010 16:36:56 GMT+00:00
Announces the Launch of Oravig(R) on the US Market by Its ... MarketWatch (press release) With a US FDA approval in April 2010, BioAlliance Pharma is the first small medium-sized innovative French company to have access to the American market, ...
The new pharmaceutical frontier - Khaleej Times
Sat, 04 Sep 2010 19:05:57 GMT+00:00
frontier Khaleej Times It has been a challenging decade for the pharmaceutical industry. With patents expiring in high numbers, new-product pipelines drying up, and intensifying ...
Sat, 04 Sep 2010 19:05:57 GMT+00:00
frontier Khaleej Times It has been a challenging decade for the pharmaceutical industry. With patents expiring in high numbers, new-product pipelines drying up, and intensifying ...
AssociatesFortune.com: Small Cap Companies in the News: Axxess Pharma, Inc ... - Trading Markets (press release)
Thu, 19 Aug 2010 16:37:17 GMT+00:00
, Inc ... Trading Markets (press release) Axxess Pharma , Inc. closed at $0.024 Wednesday, trading 332828 shares. Axxess Pharma , Inc. Reports Unauthorized and Inaccurate Press Release Distributed by ... AssociatesFortune.com: Pinksheets Companies in the News: Axxess Pharma , Inc ... Trading Markets (press release)
Thu, 19 Aug 2010 16:37:17 GMT+00:00
, Inc ... Trading Markets (press release) Axxess Pharma , Inc. closed at $0.024 Wednesday, trading 332828 shares. Axxess Pharma , Inc. Reports Unauthorized and Inaccurate Press Release Distributed by ... AssociatesFortune.com: Pinksheets Companies in the News: Axxess Pharma , Inc ... Trading Markets (press release)
Emergent BioSolutions to buy Trubion Pharma for up to $135.5 million ... - The Pharma Letter
Mon, 16 Aug 2010 10:33:44 GMT+00:00
for up to $135.5 million ... The Pharma Letter US vaccine maker Emergent BioSolutions has entered into a definitive agreement to acquire Trubion Pharmaceuticals , for upfront consideration of $96.8 ... Trubion Pharma acquired by Emergent BioSolutions BioMedReports (subscription) (blog) Emergent snaps up Trubion for up to $135.5m Pharma Times
Mon, 16 Aug 2010 10:33:44 GMT+00:00
for up to $135.5 million ... The Pharma Letter US vaccine maker Emergent BioSolutions has entered into a definitive agreement to acquire Trubion Pharmaceuticals , for upfront consideration of $96.8 ... Trubion Pharma acquired by Emergent BioSolutions BioMedReports (subscription) (blog) Emergent snaps up Trubion for up to $135.5m Pharma Times
Reckitt Benckiser Pharma receives US FDA nod for Suboxone sublingual film - pharmabiz.com
Thu, 02 Sep 2010 09:48:25 GMT+00:00
receives US FDA nod for Suboxone sublingual film pharmabiz.com Reckitt Benckiser Pharmaceuticals Inc. announces that it has received approval from the US Food and Drug Administration (FDA) for its New Drug Application ...
Thu, 02 Sep 2010 09:48:25 GMT+00:00
receives US FDA nod for Suboxone sublingual film pharmabiz.com Reckitt Benckiser Pharmaceuticals Inc. announces that it has received approval from the US Food and Drug Administration (FDA) for its New Drug Application ...
Hansen signs with Omega Pharma-Lotto for 2011 - Cyclingnews.com
Tue, 31 Aug 2010 19:02:07 GMT+00:00
-Lotto for 2011 Cyclingnews.com Australia's Adam Hansen is following his HTC-Columbia teammate Andre Greipel to Omega Pharma -Lotto in 2011. Hansen will continue to help the German sprinter ...
Tue, 31 Aug 2010 19:02:07 GMT+00:00
-Lotto for 2011 Cyclingnews.com Australia's Adam Hansen is following his HTC-Columbia teammate Andre Greipel to Omega Pharma -Lotto in 2011. Hansen will continue to help the German sprinter ...
Archimedes Pharma's PecFent nasal spray gets European marketing authorisation ... - pharmabiz.com
Sat, 04 Sep 2010 09:50:50 GMT+00:00
PecFent nasal spray gets European marketing authorisation ... pharmabiz.com Archimedes Pharma Ltd., a leading international specialty pharma company, announced that the European Commission has granted marketing authorisation for its ...
Sat, 04 Sep 2010 09:50:50 GMT+00:00
PecFent nasal spray gets European marketing authorisation ... pharmabiz.com Archimedes Pharma Ltd., a leading international specialty pharma company, announced that the European Commission has granted marketing authorisation for its ...
From Google News Search: 'pharma'
Sun Sep 5 16:11:30 2010 [ refresh local cache ]
[Hide]▼
Big Pharma's Big Problem
unknown
Mon, 16 Aug 2010 06:00:00 GM
Big . Pharma's. best patents are expiring, but it may be able to reinvent itself through acquisitions.
unknown
Mon, 16 Aug 2010 06:00:00 GM
Big . Pharma's. best patents are expiring, but it may be able to reinvent itself through acquisitions.
What is the typical credit period for pharma stockists and distributors in India?
Q. Need the answers to work on an article please.
Asked by Yash - Thu May 22 06:51:35 2008 - - 1 Answers - 0 Comments
A. one month usually. --- Master.
Answered by Master Mind - Thu May 22 07:04:51 2008
Q. Need the answers to work on an article please.
Asked by Yash - Thu May 22 06:51:35 2008 - - 1 Answers - 0 Comments
A. one month usually. --- Master.
Answered by Master Mind - Thu May 22 07:04:51 2008
[Hide]▲
















